UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

Breast cancer research : BCR, 2014-01, Vol.16 (1), p.R7-R7, Article R7

2014

Volltextzugriff (PDF)

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

Cell cycle (Georgetown, Tex.), 2009-03, Vol.8 (6), p.909-915

2009

Volltextzugriff (PDF)

Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer

Cell cycle (Georgetown, Tex.), 2016-01, Vol.15 (8), p.1046-1059

2016

Volltextzugriff (PDF)

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

Cell cycle (Georgetown, Tex.), 2009-07, Vol.8 (13), p.2031-2040

2009

Volltextzugriff (PDF)

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

Cell cycle (Georgetown, Tex.), 2012-01, Vol.11 (2), p.367-376

2012

Volltextzugriff (PDF)

Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions

Cell cycle (Georgetown, Tex.), 2011-09, Vol.10 (17), p.2959-2966

2011

Volltextzugriff (PDF)

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

Molecular cancer, 2010-12, Vol.9 (1), p.317-317, Article 317

2010

Volltextzugriff (PDF)

Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling

Breast cancer research : BCR, 2014-03, Vol.16 (2), p.R31-R31, Article R31

2014

Volltextzugriff (PDF)

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Breast cancer research and treatment, 2012-09, Vol.135 (2), p.415-432

2012

Volltextzugriff (PDF)

Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.293-293, Article 293

2019

Volltextzugriff (PDF)

Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells

Scientific reports, 2018-05, Vol.8 (1), p.6829-14, Article 6829

2018

Volltextzugriff (PDF)

Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells

International journal of cancer, 2007-05, Vol.120 (9), p.1874-1882

2007

Volltextzugriff (PDF)

Relationship of Epidermal Growth Factor Receptor Expression to ErbB-2 Signaling Activity and Prognosis in Breast Cancer Patients

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1152-1160

2005

Volltextzugriff (PDF)

Subcellular Localization of the HER4 Intracellular Domain, 4ICD, Identifies Distinct Prognostic Outcomes for Breast Cancer Patients

The American journal of pathology, 2009-11, Vol.175 (5), p.1802-1809

2009

Volltextzugriff (PDF)

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

Frontiers in oncology, 2017-11, Vol.7, p.252-252

2017

Volltextzugriff (PDF)

Glucose promotes breast cancer aggression and reduces metformin efficacy

Cell cycle (Georgetown, Tex.), 2013-12, Vol.12 (24), p.3759-3769

2013

Volltextzugriff (PDF)

Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer

Cell cycle (Georgetown, Tex.), 2023-09, p.1-20

2023

Volltextzugriff (PDF)

Measures of Cell Turnover (Proliferation and Apoptosis) and Their Association with Survival in Breast Cancer

Clinical cancer research, 2001-06, Vol.7 (6), p.1716-1723

2001

Volltextzugriff (PDF)

Estrogenic Promotion of ErbB2 Tyrosine Kinase Activity in Mammary Tumor Cells Requires Activation of ErbB3 Signaling

Molecular cancer research, 2009-11, Vol.7 (11), p.1882-1892

2009

Volltextzugriff (PDF)

Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers

Clinical cancer research, 2021-01, Vol.27 (2), p.585-597

2021

Volltextzugriff (PDF)

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer

Breast cancer research : BCR, 2013-10, Vol.15 (5), p.R101-R101, Article R101

2013

Volltextzugriff (PDF)

The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells

Oncotarget, 2016-01, Vol.7 (3), p.2921-2935

2016

Volltextzugriff (PDF)

Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression In Vivo

Cancer prevention research (Philadelphia, Pa.), 2017-03, Vol.10 (3), p.198-207

2017

Volltextzugriff (PDF)

Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers

Clinical cancer research, 2001-08, Vol.7 (8), p.2415-2424

2001

Volltextzugriff (PDF)

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells

Oncotarget, 2017-08, Vol.8 (35), p.58847-58864

2017

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(105)
Reviews
(2)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(109)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients

Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells

Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells

Relationship of Epidermal Growth Factor Receptor Expression to ErbB-2 Signaling Activity and Prognosis in Breast Cancer Patients

Subcellular Localization of the HER4 Intracellular Domain, 4ICD, Identifies Distinct Prognostic Outcomes for Breast Cancer Patients

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

Glucose promotes breast cancer aggression and reduces metformin efficacy

Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer

Measures of Cell Turnover (Proliferation and Apoptosis) and Their Association with Survival in Breast Cancer

Estrogenic Promotion of ErbB2 Tyrosine Kinase Activity in Mammary Tumor Cells Requires Activation of ErbB3 Signaling

Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer

The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells

Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression In Vivo

Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells

Suchergebnisse filtern